Transforming your biomedical data into actionable insights
We are your agile data science partner with expertise in biomedical data analysis, data mining, data integration, pipeline development, machine learning and artificial intelligence, software engineering and more.
Who we work with
We support biotech, pharmaceutical and diagnostic companies, and research institutions of all sizes to enable truly data-driven discovery, preclinical, translational and clinical R&D processes. We also have robust experience working in the animal health field as well as in supporting food and agriculture R&D.
What we do
Leveraging our expertise in advanced bioinformatics, predictive analytics & AI, bespoke software development, and data governance & architecture to support you in data-driven research and development and (pre)clinical studies.
BioLizard provided a highly professional and skilled deliverable to our request. The outcome and analysis of the hypothesis will help us in the decision-making process to identify an efficient strategy for further development of the drug product.
We help you make better, more data-driven decisions faster. Our goal? Supporting you in getting the most out of your biomedical data.
We strongly believe that creating data-driven biological insights requires a combination of computational power, human input and collaboration.
How we do it
BioLizard brings together a diverse yet complementary range of expertises to implement the most up-to-date technological tools to meet your unique data needs, now and in the future. We believe that an inclusive and open communication strategy with our clients is essential for the successful completion of each project. We ensure to align regularly with you throughout the process, and adjust pipelines to best fit your unique data case and maximize your output.
When you partner with BioLizard, you get state-of-the-art data analysis pipelines and tools to apply to your current and future research projects - and moreover, you receive end-to-end support that will make it faster and easier for you to turn your data into actionable insights. We also always ensure to fully explain our data science approach to solving your biological challenges - there’s no black box when you work with BioLizard.
A personalized, agile service model for truly impactful results
News & events
Join us in-person in New York
On 4th December in New York City, BioLizard will host a unique event diving into how we can expect AI to impact biomedicine, alongside practical use-cases demonstrating how you can stay ahead of the curve.
Be sure to catch this exclusive opportunity to listen to seasoned experts Koen Kas and Volodimir Olexiouk on the nuanced, strategic advancements that effective leveraging of AI can bring.
Seats are limited, and the event will include plenty of time to network with the speakers and fellow attendees - including at a reception over authentic Belgian beer following the formal programme.
Making smart use of AI in plant biotech R&D
On 16th January, join BioLizard and fellow thought-leaders at this tech talk meeting hosted by Flanders.bio and Agri-foodtech Flanders.
Experts from industry and academia will explore the transformative role of AI in plant biotechnology, highlighting how AI can be a strategic ally for smart & precision farming, plant biomanufacturing, and more.
BioLizard and Parean Biotechnologies announce partnership
Parean Biotechnologies and BioLizard announced their partnership. The complementarity of Parean Biotechnologies’ technologies and applications tuned to understanding the immune system and BioLizard’s tailored advanced analytics services will benefit both companies' services.
BioLizard joins Da's Geniaal consortium
We are happy to announce that BioLizard has joined the Da's Geniaal consortium, which aims to inspire youngsters between 10 and 14 years to take on more science and technology oriented studies.
BioLizard's AI expertise highlighted in European Biotechnology
"Depending on who you talk to, artificial intelligence (AI) is either a saviour or an enslaver. The concerns range from loss of jobs through to robots running society. However, in the life sciences, the use of AI and machine learning (ML) have created some excitement over their potential applications."
Our CEO Liesbeth Ceelen shares her expertise in an article published in European Biotechnology.